Nanospectra Biosciences snags funding

Nanospectra Biosciences, Inc., a medical device company, has closed on an initial $3 million in Series B-1 financing.

8 September 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles